Guest guest Posted July 18, 2001 Report Share Posted July 18, 2001 Dear group, In an email dated 7/16/01, I pointed to a web page at http://www.garynull.com/Documents/Arthritis/Antiamoebic_treatment.htm, which describes a protocol that uses antiamoebic (or anti-ameba) medicines to treat rheumatic diseases. The similarities were striking between between the anti-micoplasma (AP) prototocol by McPherson Brown, which is based on tetracycline-class antibiotics, and the anti-amoeba protocol by the Wyburn-Mason and Jack M. Blount, which is based on metronidazole and similar anti-amoeba medications. I then asked the following questions to the group: 1. Has anyone studied the anti-ameba protocol or been on it? What has been the update since 1986? (Cooky's detailed experience follows this message.) 2. Does minocycline have anti-amoebic properties? 3. Does Metronidazole have anti-micoplasma properties? 4. If minocycline and Metronidazole are both effective but address different classes of microorganisms, could these medications not be combined? What should dosages be so as not to cause over-medication or a super Herxheimer reaction? Since that time, I have done further research on the net in an attempt to find some of the answers. The web page " Alternative Treatments for Rheumatoid Arthritis " http://www.thorne.com/altmedrev/fulltext/arth4-6.html by Alan R. Gaby, MD, is a paper which appeared in Altern Med Rev 1999;4(6):392-402. It is very much worth reading, going into details about nutrition, diet and herbal remedies. It is the only paper that I have found to date which discusses the two antibiotic therapies side by side. It devotes four short paragraphs to the metronidazole therapy and one paragraph to the monocycline therapy. It is interesting to note that the author does not mention any other antibiotic therapies -- which could well exist. What is minocycline (brand name Minocin)? It is a member of the tetracycline class of antibiotics. Tetracycline, approved by the FDA in 1953, is a broad-spectrum antibiotic prepared from the cultures of certain streptomyces species. The web page http://www.rxlist.com/cgi/generic/tetcycl.htm lists the following applications: acne vulgaris; actinomycosis; amebiasis, adjunct; anthrax; conjunctivitis, infectious; gonorrhea; granuloma inguinale; infection of lower respiratory tract; infection of upper respiratory tract; infection of urinary tract; lymphogranuloma venereum; ophthalmia neonatorum; ornithosis; pneumonia; psittacosis; Q fever; relapsing fever; rickettsialpox; Rocky Mountain spotted fever; syphilis; tick fever; trachoma; typhus; 's infection; and yaws. Minocycline is a semisynthetic derivative of tetracycline with superior ability to penetrate tissues. What is metronidazole (brand name Flagyl)? It is a member of the nitroimidazole class of antibiotics. Approved by the FDA in 1963, metronidazole is a synthetic antibacterial and antiprotozoal agent that is effective therapy against protozoa such as trichomonas vaginalis, amebiasis, and giardiasis. In addition, it is one of the most effective drugs available against anaerobic bacterial infections. Metronidazole is also useful in treating Crohn's disease, antibiotic-associated diarrhea, and rosacea. The web page http://www.cai.mcgill.ca/MedEd/DrugDB/metronidazole/metronidazole_db.htm describes the following mechanism of action: " Metronidazole is amebicidal, bactericidal, and trichomonicidal. Unionized metronidazole is readily taken up by anaerobic organisms and cells. Its selectivity for anaerobic bacteria is a result of the ability of these organisms to reduce metronidazole to its active form intracellularly. The electron transport proteins necessary for this reaction are found only in anaerobic bacteria. Reduced metronidazole then disrupts DNA's helical structure, thereby inhibiting bacterial nucleic acid synthesis. This eventually results in bacterial cell death. Metronidazole is equally effective against dividing and nondividing cells. Because of its mechanism of action, low molecular weight, and limited binding to serum proteins, metronidazole is a highly lethal antimicrobial. Resistance to metronidazole is almost nonexistent. Metronidazole's spectrum of activity includes protozoa and obligate anaerobes including: Bacteroides group (including B. fragilis), Fusobacterium, Veillonella, the Clostridium group (including C. difficile and C. perfringens), Eubacterium, Peptococcus, and Peptostreptococcus. It is effective against B. fragilis isolates that are resistant to clindamycin. It is not effective against the common aerobes but is active against the aerobe Gardnerella (Haemophilus) vaginalis. The protozoan coverage of metronidazole includes Entamoeba histolytica, Giardia lamblia, and Trichomonas vaginalis. Metronidazole also has immunosuppressive and antiinflammatory actions, and it has been used in patients with rosacea. The antimicrobial actions of metronidazole alter the bacterial metabolism of bile acids in the GI tract, decreasing pruritus in patients with cholestasis secondary to primary biliary cirrhosis. " It appears that tetracycline and metronidazole are both very potent drugs and that they are effective against some of the same conditions, such as infections, but that they also each have unique antibiotic capabilities. Both have been found to be effective in treating RA and certain other rheumatoid diseases. I did a www.google.com search to look for pages where tetracycline and metronidazole are used side by side. I found three, but there may be others. The web page http://www.pslgroup.com/dg/1e4606.htm describes a new drug, Helicide by Axcan Pharma Inc. , for the eradication of Helicobacter pylori, which causes gastric and duodenal ulcers in as many as 10 percent of people in the United States at some time in their lives. Helicide is a capsule containing colloidal bismuth subcitrate (40 mg), metronidazole (125 mg) and tetracycline (125 mg). The combination of bismuth subsalicylate, metronidazole and tetracycline to eradicate Helicobacter pylori is also discussed in http://www.nursespdr.com/members/database/ndrhtml/bismuthmetronidazoletetrac ycline.html and http://www.medinfo.ufl.edu/cme/grounds/toskes/slide8.html. While ulcers and rheumatoid diseases may be unrelated, it is interesting to note that metronidazole and tetracycline are in fact being combined to increase the range of action of either drug alone. Sincerely, Harald On 7/16/01, Kathy at " Lake grove oil " <akmeyer@...> wrote: " Flagyl is also used for lyme disease in many cases. The amounts are higher. Lyme is nearly identical to syphilis (also a spirochete) and in the 60s (I believe) doctors used flagyl (metrodinazol) to treat syphlis. Basically, I believe in both flagyl and doxy and feel there are roles for each in our diseases. We do not know exactly causative factors for these immune disorders, what we have found is that many of the suspected organisms are cell wall deficient (mycoplasms, spirochetes, amoeba) and antiamoebics may target those well. In the case of lyme, the organism can morph into different types of forms (cystic, nymph, cell wall deficient ... this is my understanding.) What that might mean is that pulsing different drugs at different times might be beneficial. Also, in the case of Lyme, the bacteria replicates very slowly (every 28 days I believe) and a pulsing regime couple of times a week may be sufficient.... Our family uses doxy mwf for the most part. On full moons and half moons (approx 28 days) we try to take flagyl 10mg/lbs with meals two days in a row. (There is some evidence the bacteria divides with moon cycles). My husband likes flagyl and says his arthritis clears with flagyl (but then sometimes he says it clears with doxy). Basically we use both and interchange. I'm not advocating this regime, I feel there is a role in picking what works best for you a staying with that. Deja.com / sci.med /disease/ lyme is a great source to pick people brains about flagyl and the benefits vs. detriment. " ++++++++++++++++++++++++++++++++++++++++++++++++++ INCREASING SALES THROUGH IMPROVED MARKETING Marketing plans - sales channel development - web sites - advertising - product literature - news releases - direct mail - trade journal articles - training materials - manuals - research. Harald Weiss, Technical Marketing Group, Inc. 4911 Royce Road, Irvine, CA 92612 USA Phone: (949) 786-1403, email: hw@... Website: http://www.tmgp.com ++++++++++++++++++++++++++++++++++++++++++++++++++ Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 27, 2001 Report Share Posted July 27, 2001 karen I am very interested in " guai " is that short for guaiacum (which is a herb actually a bark from a tree that naturalpaths use in tincture form.) It was used in the 1700s I believe to treat syphilis....which is interesting because I have RA/lyme disease and the lyme bacteria is nearly identical to syphilis. (sounds a bit crazy). But if it is a form of guaiacum I would very much like to try it. kathy in oregon ra since 1998 (also three tick borne infecitions: lyme disease, erhlichiosis, and babesiosis; and one mosqueto-borne parasite infection called filariasis) Re: rheumatic Possibility of Combining Minocycline with Metronidazole > Harald, > Thank you for this information! I find it a very interesting concept. H. > pylori is so successfully treated now with the combination of antibiotics. > At first this was scoffed at by the medical community, now it's accepted > treatment. > In your searching, did you find anything about studies being done on the > combination of antibiotics for rhuematoid diseases? > I encourage you to continue enlightening us on what you find! > M. FM, RA Minocin 100 mg 3 d/wk, guai 1200 mg daily > > To unsubscribe, email: rheumatic-unsubscribeegroups > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.